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Antibiotic susceptibility of enterococci isolated from traditional
fermented meat products
J. Barbosa, V. Ferreira, P. Teixeira*
CBQF/Escola Superior de Biotecnologia, Universidade Cato´lica Portuguesa, Rua Dr. Anto´nio Bernardino de Almeida, 4200 – 072 Porto, Portugala b s t r a c t
Antibiotic susceptibility was evaluated for 182 Enterococcus spp. isolated from Alheira, Chouriça de Vinhais
and Salpica˜o de Vinhais, fermented meat products produced in the North of Portugal. Previously, a choice
was made from a group of 1060 isolates, using phenotypic and genotypic tests. From these, 76 were
previously identiﬁed as Enterococcus faecalis, 44 as Enterococcus faecium, one as Enterococcus casseliﬂavus
and 61 as Enteroccocus spp. In order to encompass several of the known chemical and functional classes, penic
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Enterococci are resistant to a wide variety of antibiotics. This
feature allows enterococci to survive in the hospital environment,
where antibiotics are used, and provides the opportunity for
dissemination of resistant organisms (Murray, 1990; Leclercq,
1997). This resistance can be both intrinsic, mediated by genes
located on the chromosome – a characteristic present in almost all
the strains of enterococci (Moellering and Krogstad, 1979) – or
acquired, mediated by genes residing on plasmids or transposons
(Murray, 1990). Resistance to cephalosporins, sulphonamides, lin-
cosamides, many b-lactams and low levels of aminoglycosides, is
recognized as intrinsic (Moellering, 1990; Murray, 1990; Leclercq,
1997; Morrison et al., 1997). The acquired genetic determinants
confer resistance to all classes of antimicrobials, including chlor-
amphenicol, tetracyclines, erythromycin, rifampicin, ampicillin and
glycopeptides. The main concern is that the genes coding for all
these antibiotic resistance traits could be transferred by phero-
mone mediated, conjugative plasmids or transposons to other
enterococci or even to more virulent pathogens (Morrison et al.,
1997; Schwarz et al., 2001).
The resistance to glycopeptides is a clinically relevant charac-
teristic (Endtz et al., 1999). Almost all Gram-positive bacteria arefax: þ351 225090351.
ira).susceptible to their activity. On the contrary, glycopeptides are
relatively large water-soluble molecules that cannot penetrate the
lipid outer membrane of Gram-negatives (Houben, 2003). Six
phenotypes have been reported for enterococci: vanA, vanB, vanC
(Moellering, 1991; Moellering and Gold, 1996), vanD (Arthur et al.,
1993), vanE (Fines et al., 1999) and, recently described, vanG
(McKessar et al., 2000).
Antibiotic-resistant enterococci have been found in meat
products, dairy products and ready-to-eat foods (Corpet, 1998;
Quednau et al., 1998; Teuber et al., 1999; Baumgartner et al., 2001;
Gomes et al., 2008; Koluman et al., 2009). In several cases, isolates
were resistant to one or more antibiotics including bacitracin,
chloramphenicol, erythromycin, gentamicin, penicillin, rifampicin,
streptomycin and tetracycline (Son et al., 1999; Teuber et al., 1999;
Hayes et al., 2004).
Some authors showed the occurrence of vancomycin-resistant
enterococci (VRE) on food of animal origin (Klein et al., 1998; Van
den Braak et al., 1998; Gomes et al., 2008; Sabia et al., 2008;
Koluman et al., 2009). There is strong evidence that this resistance
was developed through the use of the glycopeptide avoparcin in
animal production in the European Union (EU). This is probably
responsible for the increased prevalence of VRE in non-hospitalized
human populations of the EU. The glycopeptide avoparcin was
banned in Europe in 1997 and its manufacture stopped in 1999,
decreasing the prevalence of VRE in animals and human faecal
specimens (Del grosso et al., 2000; Borgen et al., 2001).
The presence of enterococci in fermented foods is controversial.
Although they exhibit interesting technological properties they are
recognized as opportunistic pathogens (Ogier and Serror, 2008).
Antibiotic resistance among enterococci isolated from food is also
a cause of concern. Hummel et al. (2007) reported the presence of
resistance genes and transposon integrase genes associated with
transferable resistances in Enterococcus spp. isolated from foods.
The aim of this workwas to evaluate the antibiotic susceptibility
of enterococci isolated from traditional fermented meat products,
produced in the north of Portugal, i.e. Alheira, Salpica˜o and Chouriça
de Vinhais.
One thousand and sixty isolates of presumptive enterococci –
Gram-positive cocci, catalase and oxidase negative, presenting
characteristic colonies on Bile Aesculin Azide Agar (BAAA) – were
investigated. Strains were previously isolated in our lab, between
September 2003 and September 2005, from Alheira (749), Salpica˜o
de Vinhais (157) and Chouriça de Vinhais (154) manufactured by 16
producers (Ferreira et al., 2006; Ferreira et al., 2007). Samples were
collected from various stages of production (in the processing
plants) and ﬁnal products (supermarkets and Feira do Fumeiro).
Isolates were grown on Brain Heart Infusion Agar (BHIA) (LabM,
Lancashire, United Kingdom) at 37 C for 24 h and stored at 80 C
in Brain Heart Infusion Broth (BHIB) containing 30% (v/v) of glycerol
(Sigma, Steinheim, Germany), and sub-cultured twice before use in
assays.
Growth of presumptive enterococci was evaluated in microtitre
plates under different conditions of temperature (10 C and 45 C),
high pH (9.6) and in the presence of 6.5% (w/v) of NaCl, according to
Devriese et al. (1993). Increased turbidity was indicative of growth
of the isolates. For each microtitre plate, non-inoculated medium
was used as a negative control. Isolates grown in BHIB at 37 C for
24 h were used as positive controls. All the tests were carried out in
duplicate.
Random Ampliﬁed Polymorphic DNA Polymerase Chain Reac-
tion (RAPD-PCR) was the method selected for typing the isolates.
The primers used for the RAPD-PCR reactions were M13 (MWG
Biotech AG, Ebersberg) (50- GAG GGT GGC GGT TCT -30) and D8635
(MWG Biotech AG,) (50- GAG CGG CCA AAG GGA GCA GAC -30) as
described by Andrighetto et al. (2001). The bacterial strain used as
reference was Enterococcus faecalis ATCC 29212.
This method was described by Destro et al. (1996) and opti-
mized in ESB FoodMicrobiology laboratory for some Gram-positive
bacteria, including enterococci. One colony of each isolate, grown
overnight at 37 C on BHIA, was resuspended in 3 ml of BHIB and
incubated overnight at 37 C. One ml of each cellular suspension
was transferred to an eppendorf tube and centrifuged at 13700 rpm
at 4 C (Rotina 35R, Hettich, Germany) for 5 min. The supernatant
was discarded and the pelleted cells were resuspended in 1 ml of
saline water (0.9% (w/v)) and centrifuged at 13700 rpm for 5 min,
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Extraction of DNAtwice. The ﬁnal cell pellets were resuspended in 50 ml of sterile
water and the eppendorf tubes were placed in boiling water for
15 min.
PCR ampliﬁcations were performed in a ThermoCycler (MyCy-
cler, Thermocycler Firmware, Bio-Rad, Richmond, CA) in 0.2 ml
reaction tubes each with 25 ml of mixtures composed of the primer
M13: 0.99 pM, 150 mM of deoxynucleoside triphosphates (dNTPs,
ABGene, Surrey, United Kingdom), 1 of PCR Buffer (MBI Fermen-
tas, Mundolsheim, France), 2.5 mM of MgCl2 (MBI Fermentas), 2U
of Taq polymerase (MBI Fermentas) and 1 ml of extracted solution of
enterococcal DNA. For the primer D8635 the mixture was
composed of 0.88 pM of primer, 200 mM of dNTPs, 1 of PCR Buffer,
2.5 mM of MgCl2, 2U of Taq polymerase and 1 ml of extracted
solution of enterococcal DNA. PCRs were performed under the
following conditions: initial cycle of 94 C for 2 min; 35 cycles of
94 C for 1 min, annealing temperature of 46.9 C for 1 min, 72 C
for 1.5 min; a ﬁnal extension step of 72 C for 10 min and thereafter
cooled to 4 C. For each PCR, a negative control (sample without
template) and a positive control (sample with DNA from strain E.
faecalis ATCC 29212) were included.
All ampliﬁcation products were combined with 3 ml of loading
buffer (Bio-Rad) and 15 ml of these mixtures were applied to
a submerged horizontal agarose gel (Seakem LE Agarose, Rock-
land, ME, USA, 1.2% (w/v)) in 1 TAE Buffer (40 mM Tris, 20 mM
acetic acid and 1 mM EDTA, pH 8.3; Bio-Rad) containing 0.5 mg/ml
of ethidium bromide. Electrophoretic separationwas at 80 V for 2 h
and, on each gel, a molecular weight marker (100 bp PCR ladder,
Bio-Rad) was included at two positions. The gels were photo-
graphed on a UV transilluminator (GelDoc2000, Bio-Rad) and
image analysis was accomplished using Quantity One software
(Bio-Rad).
RAPD-PCR proﬁles were subsequently analyzed using the Gel
Compar II Software (Applied Maths, Kortrijk, Belgium). Calculation
of the similarity of the bands proﬁles and grouping of the RAPD-
PCR patterns were based on the Pearson’s coefﬁcient and agglom-
erative clustering was performed with the unweighted pairs group
matching algorithm (UPGMA; Nilsson et al., 1998; Psoni et al.,
2006).
Based on the combined dendrogram obtained by the RAPD-PCR
patterns, isolates were arbitrarily selected for further studies by
visual inspection of all the identical proﬁles.
Identiﬁcation of isolates at species level and the detection of van
genes were performed bymultiplex-PCR according to Dukta-Malen
et al. (1995), with some modiﬁcations. Total DNA was extracted by
the guanidium thiocyanate method (Pitcher et al., 1989) and PCR
ampliﬁcations were performed in a ThermoCycler (Bio-Rad) in
0.2 ml reaction tubes each with 25 ml of mixtures using 0.5 mM of
each primer (all purchased from MWG Biotech AG), 0.1 mM of
dNTPs (ABGene), 1X of PCR Buffer (MBI Fermentas), 2 mM of MgCl2
(MBI Fermentas), 1U of Taq polymerase (MBI Fermentas) and
100 ng/ml of enterococcal DNA. Ampliﬁcation reactions were per-
formed under the following conditions: initial cycle of 94 C for
2 min; 30 cycles of 94 C for 1 min, annealing temperature of
PCR amplification
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51.6 C for 1 min, 72 C for 1 min; a ﬁnal extension step of 72 C for
10 min and thereafter cooled to 4 C. For each PCR a negative
control (sample without template) and a positive control were
included. Gel electrophoresis was done as described above in 2.4.3.
For isolates not identiﬁed at species level, a PCR assay for the
identiﬁcation of the genus Enterococcus was carried out according
to the method described by Ke et al. (1999). Total DNA was
extracted according to Pitcher et al. (1989) by using the guanidium
thiocyanate method. E. faecalis ATCC 29212 was used as a positive
control and the primers used were EntF (MWG Biotech AG) (50- TAC
TGA CAA ACC ATT CAT GAT G -30) and EntR (MWG Biotech AG,
Ebersberg) (50- AAC TTC GTC ACC AAC GCG AAC -30).
The minimum inhibitory concentration – MIC (mg/mL) of nine
antibiotics was determined for all isolates by the agar microdilution
method, according to the National Committee for Clinical Labora-
tory Standards (NCCLS, 2004). Each test was carried on Muller-
Hinton agar (MHA) (BioMe´rieux, Marcy l’Etoile, France) with
cations adjusted for penicillin G (Sigma) and ampicillin (Fluka,
Steinheim, Germany) and on MHA for the other seven antibiotics –
vancomycin and chloramphenicol (both from Fluka), nitrofurantoin
(Sigma), erythromycin, tetracycline, ciproﬂoxacin and rifampicin
(kindly supplied by the company Labesfal, Tondela, Portugal).
Antibiotic concentrations ranged from 0.03 to 512 mg/ml. Table 2D
(MIC Interpretative Standards (mg/ml) for Enterococcus spp.) in
NCCLS (2004) was consulted in order to classify the isolates
according to their susceptibility (sensitive, intermediate or
resistant).
Each experiment was performed in duplicate and all the isolates
were grown on plates of MHA and MHAwith cations adjusted with
no antibiotic. The quality control strains E. faecalis ATCC 29212 and
Staphylococcus aureus ATCC 29213 were used to monitor the
accuracy of MICs (NCCLS, 2004).
Isolates showing an intermediate resistance to vancomycin
(MICs in the range of 8–16 mg/ml) were submitted to a screening-
test according to NCCLS (2004); three antibiotics were used at
different concentrations: gentamicin at 500 mg/ml, streptomycin at
2000 mg/ml and vancomycin at 6 mg/ml, all on BHIA. All experi-
ments were done in duplicate and the strains E. faecalis DSMZ
12956 (resistant to all the antibiotics) and E. faecalis ATCC 29212
(susceptible to all the antibiotics) were used as controls.
The 1060 isolates investigated were Gram-positive cocci, cata-
lase and oxidase negative and hydrolyzed aesculin to esculetin
when cultured on BAAA. Isolates that grew at temperatures of 10 C
and 45 C, in the presence of 6.5% (w/v) of NaCl and at pH 9.6, were
selected for further characterization. According to some authors
(Collins et al., 1984; Devriese et al., 1990, 1993; Murray, 1990;
Martı´nez-Murcia and Collins, 1991; Svec et al., 2001; Vancanneyt
et al., 2004) a few species may not grow in one of these conditions,
but all grow at pH 9.6. So, isolates that did not grow at 10 C, 45 C
or in presence of NaCl, but hydrolyzed aesculin and grew at pH 9.6
were also chosen. From 1060 isolates, 782 were selected.
Since there were a large number of isolates, it was important to
group them in order to reduce the number of strains for further
studies and to avoid the study of multiple isolates of the same
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vancomycin resistancestrain. A combined dendrogram for both primers M13 and D8635
was achieved. As the dendrogram was extremely large, being
difﬁcult to analyze (since it was done for all 782 isolates), an indi-
vidual combined dendrogram was done for each producer, which
presented a cophenetic correlation value in the range 0.6–1.0 (data
not shown). Seven different proﬁles, in agarose gel, were obtained
for the primer M13 and 11 for the primer D8635. Approximately 7–
15 distinct bands, which ranged in size from 200 to 1400 bp, were
observed with primer M13, while D8635 produced a slightly lower
number of bands (6–12), which ranged in size from 200 to 3000 bp.
The selection of isolates for further studies was done arbitrarily in
order to have at least one isolate representative of each combined
proﬁle per producer. The number of isolates was reduced from 782
to 182.
From 182 isolates, 76 had PCR products of 941 bp, which was
a result from ampliﬁcation of portions of the ddlE. faecalis and 44
isolates had PCR products of 550 bp from ampliﬁcation of portions
of the ddlEnterococcus faecium. Therefore, 76 isolates were identiﬁed as
E. faecalis and 44 as E. faecium. A band of 439 bp, corresponding to
ampliﬁcation of vanC-2/3, was observedwith DNA from one isolate.
vanC-2 and vanC-3 genes are almost identical (98% identity), so this
isolate could be classiﬁed as Enterococcus casseliﬂavus or Entero-
coccus ﬂavescens. In the present work, this isolate was classiﬁed as
E. casseliﬂavus. Although being easy and rapid to perform and quite
inexpensive, this method does not allow the identiﬁcation of a high
number of species. DNA from 61 isolates was not ampliﬁed and
consequently their identiﬁcation to species level was not possible.
For those isolates not identiﬁed by the method described by Dukta-
Malen et al. (1995), a genus-speciﬁc PCR, was used. A PCR product
with 112 bp was obtained for all the isolates, conﬁrming that all of
these isolates belong to the genus Enterococcus.
Antibiotic susceptibility of enterococcal isolates was evaluated
for ampicillin, penicillin, erythromycin, vancomycin, tetracycline,
chloramphenicol, ciproﬂoxacin, rifampicin and nitrofurantoin, in
order to cover some of the known chemical and functional classes
of antibiotics. The MIC (mg/ml), the lowest concentration without
visible growth, was determined and the MIC value distributions of
the 182 enterococcal isolates are listed in Table 1. Based on MICs,
isolates were classiﬁed as resistant, intermediate or sensitive to
each of the antibiotics investigated, according to NCCLS guidelines
(2004; Table 1). It is important to emphasise that although in vitro
antibiotic susceptibility testing should be used as a guide to assess
microbial sensitivities to various antibiotics, it does not always
reﬂect the in vivo situation (Blaser et al., 1995).
Enterococci are considered intrinsically resistant to b-lactam
antibiotics (Kak and Chow, 2002). The results obtained in the
present study are not in agreement with this generalization since
all isolates were sensitive to both ampicillin and penicillin. Other
authors obtained similar results (Peters et al., 2003; Ben Omar et al.,
2004; McGowan-Spicer et al., 2008; Valenzuela et al., 2008). In
a previous study with clinical and food isolates, Lopes et al. (2005)
stated that resistance of enterococci to b-lactam antibiotics seems
to be associated with clinical strains and often inaccurately gener-
alized in the literature to the genus.
Fluoroquinolones belong to a group of antibiotics with a large
spectrum of activity against Gram-negative and Gram-positive
organisms, but exhibit only a weak effect on enterococci (Peters
et al., 2003). In fact, of the 182 isolates investigated, only 12 (6.6%)
demonstrated sensitivity to ciproﬂoxacin. This resistance may be
a result of the overwhelming use of antibiotics in human and
veterinary medicine (Appelbaum and Hunter, 2000).
For human treatment, the use of chloramphenicol is low,
because of its side effects and the use in animal husbandry was
banned in Europe in 1994 (Peters et al., 2003). Despite this fact, and
even though almost all the isolates (172; 94.5%) were sensitive to
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)this antibiotic, one (0.5%) isolate was resistant and nine (5.0%)
showed intermediate resistance. Other authors (Lautenbach et al.,
1998; Low et al., 2001) reported the potential for the emergence of
chloramphenicol resistance in enterococci.
For the antibiotic erythromycin, a high percentage of food
isolates was classiﬁed as intermediate (87; 47.8%) or resistant (33;
18.1%). The same results were obtained by other authors (Mannu
et al., 2003; Peters et al., 2003). The resistance to erythromycin as
a representative of the macrolide antibiotics is a matter of concern,
because macrolides are common substitutes used in patients with
a penicillin allergy.
Nitrofurantoin is a successful antibiotic used to treat urinary
tract infections caused by vancomycin-resistant enterococci and it
was active against 93 (51.1%) isolates tested. Similar results were
previously reported (Hayes et al., 2003; Quin˜ones et al., 2005).
However, 11 (6%) isolates were resistant to this antibiotic.
A high proportion of strains were resistant to rifampicin: 109
(60.0%) isolates were resistant. With the exception of one producer,
resistant strains were isolated from products from all the producers.
Rifampicin is almost exclusively used to treat tuberculosis. A very
interesting study with enterococci was performed by Costa et al.
(2006) in Portugal using strains isolated from municipal sewage
treatment plants. A high proportion of strains from the 14 municipal
treatment plants showed rifampicin resistance. One of the higher
frequencies of rifampicin resistance was in Macedo de Cavaleiros.
This is an interesting report in view of fact thatMacedo de Cavaleiros
belongs to Tra´s-os-Montes region, where all the fermented meat
products investigated were manufactured.
The wide use of tetracycline in husbandry activities is a possible
explanation for the high level of tetracycline resistance frequently
found among enterococci (Busani et al., 2004; Hayes et al., 2004). In
this study, 41 (22.5%) isolates were resistant to this antibiotic.
Vancomycin-resistant enterococci have emerged in the last
decade as a frequent cause of nosocomial infections (Rice, 2001).
None of the studied isolates was resistant to vancomycin. Other
authors obtained similar results for food isolates (Mannu et al.,
2003; Peters et al., 2003; Majhenicˇ et al., 2005; Messi et al., 2006).
However, one isolate presented intermediate resistance to vanco-
mycin. In these cases, according to NCCLS guidelines (2004),
a screening-test for high-level aminoglycoside resistance should be
done. Enterococci possess a natural low-level resistance to ami-
noglycosides and the high-level resistance rarely occurs (Murray,
1990). The screening-test revealed that the isolate was sensitive to
gentamicin and to streptomycin. This means that these amino-
glycosides could be used to treat a hypothetical infection with this
isolate or even used in combinationwith vancomycin. Combination
therapy with vancomycin plus an aminoglycoside is usually indi-
cated for serious enterococcal infections, such as endocarditis
(NCCLS, 2004).
No isolates were found to carry vanA or vanB genotype and were
sensitive to vancomycin (MIC 4 mg/ml). The only isolate, showing
moderate resistance to vancomycin (MIC¼ 8 mg/ml), was positive
for the vanC-2/C3 gene, and was identiﬁed as E. casseliﬂavus; vanC
type is an intrinsic property of motile enterococci (Navarro and
Courvalin,1994). The presence of the vanA gene in Enterococcus spp.
is associated with high vancomycin resistance (MIC¼ 64–
>1000 mg/ml), while vanB (MIC¼ 4–1024 mg/ml) and vanC
(MIC¼ 2–32 mg/ml) are associated with medium to low levels of
vancomycin resistance, respectively (Cetinkaya et al., 2000). A good
correlation was observed between the MIC values for vancomycin
and the absence of vanA and vanB genes in Enterococcus isolates.
Resistance to multiple antibiotics was observed. All isolates
were resistant to at least 2 antibiotics, with the exception of 11
isolates that were resistant to three antibiotics and 4 isolates that
Table 2
Multiple resistance phenotypes among food isolates.
Antimicrobial resistance pattern Number of food isolates (%)
Cip Rif 14 (7.7)
Tet Rif 16 (8.8)
Eri Rif 21 (11.5)
Cip Tet 2 (1.1)
Nit Rif 1 (0.5)
Eri Nit 2 (1.1)
Nit Rif Tet 3 (1.6)
Cip Rif Tet 2 (1.1)
Cip Nit Tet 1 (0.5)
Cip Eri Rif 4 (2.2)
Eri Rif Tet 1 (0.5)
Eri Nit Rif Tet 1 (0.5)
Cip Eri Rif Tet 2 (1.1)
Cip Eri Chl Rif 1 (0.5)
Cip (Ciproﬂoxacin), Chl (Chloramphenicol), Eri (Erythromycin), Nit (Nitrofurantoin),
Rif (Rifampicin), Tet (Tetracycline).were resistant to four antibiotics. Proﬁles of multiple resistance of
isolates to the selected antimicrobials are presented in Table 2.
Resistances to several antibiotics (tetracycline, rifampicin,
erythromycin, ciproﬂoxacin, nitrofurantoin and chloramphenicol)
as well as sensitivity to ampicillin and penicillin were also found in
recent studies with enterococci, such as the studies of McGowan-
Spicer et al. (2008), Valenzuela et al. (2008) and Valenzuela et al.
(2009). In a particular study with enterococci isolated from poultry
in Portugal, Poeta et al. (2006) observed that a high proportion of
strains were resistant to tetracycline (97%), erythromycin (88%);
lower proportions were resistant to chloramphenicol (16%) and
ampicillin (10%). In the production of fermented products such as
Alheira, poultry meats are used in their manufacture and interest-
ingly, with the exception of ampicillin, similar resistance patterns
were observed in the current study.
Some differences in resistance rates could be associatedwith the
enterococcal species. Of E. faecalis isolates, 38.2% were resistant to
tetracycline, while only 2.3% of the E. faeciumwere resistant. More E.
faecium strains were resistant to erythromycin (36.4%) than E. fae-
calis isolates (9.2%). Both specieswere observed to exhibit resistance
to rifampicin as well as similar sensitivity to other antibiotics.
A consequence of nosocomial infections associated with
enterococci and the difﬁculty of treating such infections due to
antibiotic resistance, are matters of concern. The presence of other
resistances and the ability for enterococci to acquire resistance
genes by natural-conjugation gene transfer processes is such
a problem. In a previous study (data not shown) the occurrence of
virulence factors in these enterococci, emphasized the importance
of the current study. Overall, from the clinical perspective,
assuming that an infection by these food isolates is possible, their
susceptibility to antibiotics commonly used to treat enterococcal
diseases, such as penicillins and vancomycin (last resort for treat-
ment of multiple-resistant enterococcal infections), is a positive
indication for treatment.
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